Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Operating Income Loss of -$4.23 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +64.4% in Operating Income Loss from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2013 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$3.0 thousand | Q2 2013: -$14.8 thousand | Q3 2013: -$4.7 thousand | Q1 2014: -$3.9 thousand | Q2 2014: -$16.0 thousand | Q3 2014: -$6.1 thousand | Q1 2015: -$1.8 thousand | Q2 2015: -$18.7 thousand | Q3 2015: -$2.6 thousand | Q1 2016: -$4.4 thousand | Q2 2016: -$14.1 thousand | Q3 2016: -$8.6 thousand | Q1 2017: -$516.1 thousand | Q2 2017: -$888.7 thousand | Q3 2017: -$893.8 thousand | Q4 2017: -$773.8 thousand | Q1 2018: -$1.10 million | Q2 2018: -$1.17 million | Q4 2018: -$1.08 million | Q1 2019: -$1.52 million | Q2 2019: -$1.86 million | Q4 2019: -$1.81 million | Q1 2020: -$1.38 million | Q2 2020: -$1.59 million | Q4 2020: -$2.14 million | Q1 2021: -$2.40 million | Q2 2021: -$3.03 million | Q4 2021: -$2.81 million | Q1 2022: -$3.06 million | Q2 2022: -$2.76 million | Q4 2022: -$1.78 million | Q1 2023: -$3.50 million | Q2 2023: -$3.51 million | Q4 2023: -$3.39 million | Q1 2024: -$2.89 million | Q2 2024: -$2.79 million | Q4 2024: $1.71 million | Q1 2025: -$2.68 million | Q2 2025: -$1.89 million | Q4 2025: -$1.71 million.
- Over the full 11 years of available data (2013 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Operating Income Loss has declined by 16,743.2%.
- Historical annual values: Fiscal year 2025: -$4.23 million | Fiscal year 2024: -$11.89 million | Fiscal year 2023: -$11.96 million | Fiscal year 2022: -$10.03 million | Fiscal year 2021: -$10.22 million | Fiscal year 2020: -$4.90 million | Fiscal year 2019: -$5.81 million | Fiscal year 2016: -$32.6 thousand | Fiscal year 2015: -$30.9 thousand | Fiscal year 2014: -$35.9 thousand | Fiscal year 2013: -$25.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: